Symbols / IQV Stock $162.28 +1.00% IQVIA Holdings Inc.

Healthcare • Diagnostics & Research • United States • NYQ
IQV (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. Ari Bousbib
Exch · Country NYQ · United States
Market Cap 27.24B
Enterprise Value 41.83B
Income 1.36B
Sales 16.31B
FCF (ttm) 2.22B
Book/sh 38.34
Cash/sh 12.62
Employees 93,000
Insider 10d —
IPO May 09, 2013
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 20.70
Forward P/E 11.53
PEG 0.68
P/S 1.67
P/B 4.23
P/C —
EV/EBITDA 14.24
EV/Sales 2.56
Quick Ratio 0.67
Current Ratio 0.75
Debt/Eq 245.93
LT Debt/Eq —
EPS (ttm) 7.84
EPS next Y 14.08
EPS Growth 23.60%
Revenue Growth 10.30%
EPS Gr Q/Q 17.60%
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-05
ROA 5.05%
ROE 21.44%
ROIC —
Gross Margin 33.29%
Oper. Margin 15.17%
Profit Margin 8.34%
Shs Outstand 167.87M
Shs Float 161.25M
Insider Own 1.09%
Instit Own 103.04%
Short Float 3.31%
Short Ratio 3.34
Short Interest 4.81M
52W High 247.05
vs 52W High -34.31%
52W Low 134.65
vs 52W Low 20.52%
Beta 1.39
Impl. Vol. 0.78%
Rel Volume 0.41
Avg Volume 2.15M
Volume 881.41K
Target (mean) $231.60
Tgt Median $229.00
Tgt Low $185.00
Tgt High $287.00
# Analysts 20
Recom Strong_buy
Prev Close $160.68
Price $162.28
Change 1.00%
About

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$231.60
Mean price target
2. Current target
$162.28
Latest analyst target
3. DCF / Fair value
$237.68
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$162.28
Low
$185.00
High
$287.00
Mean
$231.60

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-08 main Evercore ISI Group Outperform → Outperform $185
2026-03-09 up TD Cowen Hold → Buy $213
2026-03-06 up Barclays Equal-Weight → Overweight $210
2026-03-03 init RBC Capital — → Outperform $221
2026-02-19 main Truist Securities Buy → Buy $245
2026-02-06 main JP Morgan Overweight → Overweight $225
2026-02-06 main Citigroup Neutral → Neutral $200
2026-02-06 main UBS Buy → Buy $240
2026-02-06 main Jefferies Buy → Buy $255
2026-02-06 main Stifel Buy → Buy $220
2026-02-06 main Barclays Equal-Weight → Equal-Weight $210
2026-01-22 main TD Cowen Hold → Hold $245
2026-01-08 main Truist Securities Buy → Buy $290
2026-01-08 main UBS Buy → Buy $280
2025-12-02 main Morgan Stanley Overweight → Overweight $265
2025-11-13 init BMO Capital — → Outperform $260
2025-11-03 down TD Cowen Buy → Hold $215
2025-10-29 main Citigroup Neutral → Neutral $230
2025-10-29 main UBS Buy → Buy $250
2025-10-29 main Stifel Buy → Buy $254
News
RSS: Latest IQV news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-06 BOUSBIB ARI B Chief Executive Officer — 57,177 $0.00 $0
2026-02-06 BRUEHLMAN RONALD E Chief Financial Officer — 16,335 $0.00 $0
2026-02-06 SHERBET ERIC M General Counsel — 6,806 $0.00 $0
2026-02-06 STAUB WALTER. RICHARD III Officer — 2,722 $0.00 $0
2026-02-06 CHEROFSKY KERIANN Officer — 1,087 $0.00 $0
2026-02-06 PATEL BHAVIK Officer — 4,083 $0.00 $0
2026-02-06 GRENFELL ALISTAIR Officer — 11,795 $0.00 $0
2025-12-18 BOUSBIB ARI B Chief Executive Officer — 36,564 $222.43 $8,132,931
2025-12-18 BOUSBIB ARI B Chief Executive Officer — 50,000 $59.90 $2,995,000
2025-10-29 BOUSBIB ARI B Chief Executive Officer — 56,557 $217.58 $12,461,119
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
16,310.00
+5.87%
15,405.00
+2.81%
14,984.00
+3.98%
14,410.00
Operating Revenue
16,310.00
+5.87%
15,405.00
+2.81%
14,984.00
+3.98%
14,410.00
Cost Of Revenue
10,880.00
+8.47%
10,030.00
+2.92%
9,745.00
+3.87%
9,382.00
Reconciled Cost Of Revenue
10,880.00
+8.47%
10,030.00
+2.92%
9,745.00
+3.87%
9,382.00
Gross Profit
5,430.00
+1.02%
5,375.00
+2.60%
5,239.00
+4.20%
5,028.00
Operating Expense
3,143.00
+1.19%
3,106.00
-2.27%
3,178.00
-0.72%
3,201.00
Selling General And Administration
1,999.00
+0.35%
1,992.00
-2.97%
2,053.00
-0.87%
2,071.00
Total Expenses
14,023.00
+6.75%
13,136.00
+1.65%
12,923.00
+2.70%
12,583.00
Operating Income
2,287.00
+0.79%
2,269.00
+10.09%
2,061.00
+12.81%
1,827.00
Total Operating Income As Reported
2,182.00
-0.91%
2,202.00
+11.38%
1,977.00
+9.89%
1,799.00
EBITDA
3,464.00
+0.32%
3,453.00
+6.05%
3,256.00
+11.93%
2,909.00
Normalized EBITDA
3,575.00
+1.56%
3,520.00
+5.20%
3,346.00
+13.93%
2,937.00
Reconciled Depreciation
1,144.00
+2.69%
1,114.00
-0.98%
1,125.00
-0.44%
1,130.00
EBIT
2,320.00
-0.81%
2,339.00
+9.76%
2,131.00
+19.79%
1,779.00
Total Unusual Items
-111.00
-65.67%
-67.00
+25.56%
-90.00
-221.43%
-28.00
Total Unusual Items Excluding Goodwill
-111.00
-65.67%
-67.00
+25.56%
-90.00
-221.43%
-28.00
Special Income Charges
-111.00
-65.67%
-67.00
+25.56%
-90.00
-221.43%
-28.00
Other Special Charges
6.00
—
6.00
—
Restructuring And Mergern Acquisition
105.00
+56.72%
67.00
-20.24%
84.00
+200.00%
28.00
Net Income
1,360.00
-0.95%
1,373.00
+1.10%
1,358.00
+24.47%
1,091.00
Pretax Income
1,591.00
-4.67%
1,669.00
+14.39%
1,459.00
+7.04%
1,363.00
Net Non Operating Interest Income Expense
-684.00
-9.79%
-623.00
+2.04%
-636.00
-57.82%
-403.00
Interest Expense Non Operating
729.00
+8.81%
670.00
-0.30%
672.00
+61.54%
416.00
Net Interest Income
-684.00
-9.79%
-623.00
+2.04%
-636.00
-57.82%
-403.00
Interest Expense
729.00
+8.81%
670.00
-0.30%
672.00
+61.54%
416.00
Interest Income Non Operating
45.00
-4.26%
47.00
+30.56%
36.00
+176.92%
13.00
Interest Income
45.00
-4.26%
47.00
+30.56%
36.00
+176.92%
13.00
Other Income Expense
-12.00
-152.17%
23.00
-32.35%
34.00
+155.74%
-61.00
Other Non Operating Income Expenses
99.00
+10.00%
90.00
-27.42%
124.00
+475.76%
-33.00
Tax Provision
252.00
-16.28%
301.00
+198.02%
101.00
-61.15%
260.00
Tax Rate For Calcs
0.00
-12.22%
0.00
+160.87%
0.00
-63.87%
0.00
Tax Effect Of Unusual Items
-17.54
-45.42%
-12.06
-94.20%
-6.21
-16.12%
-5.35
Net Income Including Noncontrolling Interests
1,361.00
-0.87%
1,373.00
+1.10%
1,358.00
+24.47%
1,091.00
Net Income From Continuing Operation Net Minority Interest
1,360.00
-0.95%
1,373.00
+1.10%
1,358.00
+24.47%
1,091.00
Net Income From Continuing And Discontinued Operation
1,360.00
-0.95%
1,373.00
+1.10%
1,358.00
+24.47%
1,091.00
Net Income Continuous Operations
1,361.00
-0.87%
1,373.00
+1.10%
1,358.00
+24.47%
1,091.00
Minority Interests
-1.00
0.00
0.00
0.00
Normalized Income
1,453.46
+1.79%
1,427.94
-0.96%
1,441.79
+29.47%
1,113.65
Net Income Common Stockholders
1,360.00
-0.95%
1,373.00
+1.10%
1,358.00
+24.47%
1,091.00
Diluted EPS
7.84
+4.67%
7.49
+2.74%
7.29
+27.45%
5.72
Basic EPS
7.91
+4.49%
7.57
+2.44%
7.39
+26.98%
5.82
Basic Average Shares
171.90
-5.18%
181.30
-1.36%
183.80
-2.03%
187.60
Diluted Average Shares
173.50
-5.40%
183.40
-1.56%
186.30
-2.26%
190.60
Diluted NI Availto Com Stockholders
1,360.00
-0.95%
1,373.00
+1.10%
1,358.00
+24.47%
1,091.00
Depreciation Amortization Depletion Income Statement
1,144.00
+2.69%
1,114.00
-0.98%
1,125.00
-0.44%
1,130.00
Depreciation And Amortization In Income Statement
1,144.00
+2.69%
1,114.00
-0.98%
1,125.00
-0.44%
1,130.00
Earnings From Equity Interest Net Of Tax
22.00
+340.00%
5.00
0.00
+100.00%
-12.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
29,944.00
+11.32%
26,899.00
+0.82%
26,681.00
+5.30%
25,337.00
Current Assets
6,249.00
+7.21%
5,829.00
+4.16%
5,596.00
+12.35%
4,981.00
Cash Cash Equivalents And Short Term Investments
2,141.00
+16.17%
1,843.00
+23.20%
1,496.00
+14.29%
1,309.00
Cash And Cash Equivalents
1,980.00
+16.33%
1,702.00
+23.69%
1,376.00
+13.16%
1,216.00
Cash Financial
1,980.00
+16.33%
1,702.00
+23.69%
1,376.00
+13.16%
1,216.00
Other Short Term Investments
161.00
+14.18%
141.00
+17.50%
120.00
+29.03%
93.00
Receivables
3,427.00
+5.77%
3,240.00
-5.07%
3,413.00
+15.30%
2,960.00
Accounts Receivable
1,668.00
+20.00%
1,390.00
-5.63%
1,473.00
+10.84%
1,329.00
Receivables Adjustments Allowances
-51.00
-21.43%
-42.00
-23.53%
-34.00
+5.56%
-36.00
Other Receivables
1,783.00
-3.93%
1,856.00
-4.43%
1,942.00
+19.58%
1,624.00
Taxes Receivable
27.00
-25.00%
36.00
+12.50%
32.00
-25.58%
43.00
Prepaid Assets
162.00
+5.19%
154.00
+9.22%
141.00
-6.62%
151.00
Other Current Assets
519.00
-12.33%
592.00
+8.42%
546.00
-2.67%
561.00
Total Non Current Assets
23,695.00
+12.46%
21,070.00
-0.07%
21,085.00
+3.58%
20,356.00
Net PPE
823.00
+6.47%
773.00
-5.62%
819.00
-5.10%
863.00
Gross PPE
1,728.00
+8.54%
1,592.00
-1.85%
1,622.00
-4.76%
1,703.00
Accumulated Depreciation
-905.00
-10.50%
-819.00
-1.99%
-803.00
+4.40%
-840.00
Properties
385.00
+4.90%
367.00
-2.39%
376.00
+3.58%
363.00
Machinery Furniture Equipment
150.00
+2.04%
147.00
+0.00%
147.00
-6.37%
157.00
Other Properties
1,193.00
+10.67%
1,078.00
-1.91%
1,099.00
-7.10%
1,183.00
Goodwill And Other Intangible Assets
21,578.00
+12.33%
19,209.00
-1.02%
19,406.00
+3.55%
18,741.00
Goodwill
16,616.00
+12.96%
14,710.00
+0.98%
14,567.00
+4.64%
13,921.00
Other Intangible Assets
4,962.00
+10.29%
4,499.00
-7.03%
4,839.00
+0.39%
4,820.00
Investments And Advances
432.00
+15.51%
374.00
+56.49%
239.00
+47.53%
162.00
Long Term Equity Investment
324.00
+21.80%
266.00
+98.51%
134.00
+42.55%
94.00
Non Current Deferred Assets
357.00
+84.02%
194.00
+16.87%
166.00
+40.68%
118.00
Non Current Deferred Taxes Assets
357.00
+84.02%
194.00
+16.87%
166.00
+40.68%
118.00
Non Current Prepaid Assets
—
—
—
472.00
Other Non Current Assets
505.00
-2.88%
520.00
+14.29%
455.00
-3.60%
472.00
Total Liabilities Net Minority Interest
23,314.00
+11.91%
20,832.00
+1.28%
20,569.00
+5.09%
19,572.00
Current Liabilities
8,338.00
+19.85%
6,957.00
+7.18%
6,491.00
+16.37%
5,578.00
Payables And Accrued Expenses
2,990.00
+1.87%
2,935.00
+8.22%
2,712.00
+8.61%
2,497.00
Payables
920.00
+3.14%
892.00
+8.12%
825.00
+2.36%
806.00
Accounts Payable
780.00
+5.98%
736.00
+3.81%
709.00
+9.92%
645.00
Current Accrued Expenses
2,070.00
+1.32%
2,043.00
+8.27%
1,887.00
+11.59%
1,691.00
Pensionand Other Post Retirement Benefit Plans Current
901.00
-0.44%
905.00
-6.51%
968.00
-1.22%
980.00
Total Tax Payable
140.00
-10.26%
156.00
+34.48%
116.00
-27.95%
161.00
Income Tax Payable
140.00
-10.26%
156.00
+34.48%
116.00
-27.95%
161.00
Current Debt And Capital Lease Obligation
1,840.00
+60.70%
1,145.00
+59.47%
718.00
+372.37%
152.00
Current Debt
1,840.00
+60.70%
1,145.00
+59.47%
718.00
+372.37%
152.00
Current Deferred Liabilities
2,118.00
+19.06%
1,779.00
-1.11%
1,799.00
+0.11%
1,797.00
Current Deferred Revenue
2,118.00
+19.06%
1,779.00
-1.11%
1,799.00
+0.11%
1,797.00
Other Current Liabilities
489.00
+153.37%
193.00
-34.35%
294.00
+93.42%
152.00
Total Non Current Liabilities Net Minority Interest
14,976.00
+7.94%
13,875.00
-1.44%
14,078.00
+0.60%
13,994.00
Long Term Debt And Capital Lease Obligation
14,109.00
+8.44%
13,011.00
-1.27%
13,178.00
+2.48%
12,859.00
Long Term Debt
13,884.00
+8.15%
12,838.00
-0.90%
12,955.00
+2.86%
12,595.00
Long Term Capital Lease Obligation
225.00
+30.06%
173.00
-22.42%
223.00
-15.53%
264.00
Non Current Deferred Liabilities
179.00
-8.67%
196.00
-2.97%
202.00
-56.47%
464.00
Non Current Deferred Taxes Liabilities
179.00
-8.67%
196.00
-2.97%
202.00
-56.47%
464.00
Other Non Current Liabilities
688.00
+2.99%
668.00
-4.30%
698.00
+4.02%
671.00
Stockholders Equity
6,503.00
+7.19%
6,067.00
-0.74%
6,112.00
+6.02%
5,765.00
Common Stock Equity
6,503.00
+7.19%
6,067.00
-0.74%
6,112.00
+6.02%
5,765.00
Capital Stock
3.00
+0.00%
3.00
+0.00%
3.00
-99.97%
10,898.00
Common Stock
3.00
+0.00%
3.00
+0.00%
3.00
-99.97%
10,898.00
Share Issued
259.10
+0.35%
258.20
+0.39%
257.20
+0.31%
256.40
Ordinary Shares Number
169.60
-3.69%
176.10
-2.98%
181.50
-2.26%
185.70
Treasury Shares Number
89.50
+9.01%
82.10
+8.45%
75.70
+7.07%
70.70
Additional Paid In Capital
11,375.00
+2.11%
11,140.00
+1.04%
11,025.00
+1.19%
10,895.00
Retained Earnings
7,425.00
+22.42%
6,065.00
+29.26%
4,692.00
+40.73%
3,334.00
Gains Losses Not Affecting Retained Earnings
-943.00
+9.15%
-1,038.00
-19.72%
-867.00
-19.26%
-727.00
Treasury Stock
11,357.00
+12.41%
10,103.00
+15.58%
8,741.00
+12.93%
7,740.00
Minority Interest
127.00
0.00
—
0.00
Other Equity Adjustments
-943.00
+9.15%
-1,038.00
-19.72%
-867.00
-19.26%
-727.00
Total Equity Gross Minority Interest
6,630.00
+9.28%
6,067.00
-0.74%
6,112.00
+6.02%
5,765.00
Total Capitalization
20,387.00
+7.84%
18,905.00
-0.85%
19,067.00
+3.85%
18,360.00
Working Capital
-2,089.00
-85.20%
-1,128.00
-26.03%
-895.00
-49.92%
-597.00
Invested Capital
22,227.00
+10.86%
20,050.00
+1.34%
19,785.00
+6.88%
18,512.00
Total Debt
15,949.00
+12.67%
14,156.00
+1.87%
13,896.00
+6.80%
13,011.00
Net Debt
13,744.00
+11.91%
12,281.00
-0.13%
12,297.00
+6.64%
11,531.00
Capital Lease Obligations
225.00
+30.06%
173.00
-22.42%
223.00
-15.53%
264.00
Net Tangible Assets
-15,075.00
-14.71%
-13,142.00
+1.14%
-13,294.00
-2.45%
-12,976.00
Tangible Book Value
-15,075.00
-14.71%
-13,142.00
+1.14%
-13,294.00
-2.45%
-12,976.00
Interest Payable
85.00
+4.94%
81.00
+22.73%
66.00
+53.49%
43.00
Investmentin Financial Assets
108.00
+0.00%
108.00
+2.86%
105.00
+54.41%
68.00
Investmentsin Associatesat Cost
—
—
134.00
+42.55%
94.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
2,654.00
-2.28%
2,716.00
+26.38%
2,149.00
-4.91%
2,260.00
Cash Flow From Continuing Operating Activities
2,654.00
-2.28%
2,716.00
+26.38%
2,149.00
-4.91%
2,260.00
Net Income From Continuing Operations
1,361.00
-0.87%
1,373.00
+1.10%
1,358.00
+24.47%
1,091.00
Depreciation Amortization Depletion
1,144.00
+2.69%
1,114.00
-0.98%
1,125.00
-0.44%
1,130.00
Depreciation
160.00
+7.38%
149.00
-1.32%
151.00
-5.63%
160.00
Amortization Cash Flow
984.00
+1.97%
965.00
-0.92%
974.00
+0.41%
970.00
Depreciation And Amortization
1,144.00
+2.69%
1,114.00
-0.98%
1,125.00
-0.44%
1,130.00
Amortization Of Intangibles
984.00
+1.97%
965.00
-0.92%
974.00
+0.41%
970.00
Other Non Cash Items
23.00
+9.52%
21.00
+16.67%
18.00
+20.00%
15.00
Stock Based Compensation
247.00
+19.90%
206.00
-5.07%
217.00
+11.86%
194.00
Deferred Tax
-180.00
-39.53%
-129.00
+52.04%
-269.00
-133.91%
-115.00
Deferred Income Tax
-180.00
-39.53%
-129.00
+52.04%
-269.00
-133.91%
-115.00
Operating Gains Losses
-66.00
-144.44%
-27.00
-35.00%
-20.00
-168.97%
29.00
Gain Loss On Investment Securities
-44.00
-100.00%
-22.00
-10.00%
-20.00
-174.07%
27.00
Gain Loss On Sale Of PPE
—
0.00
0.00
+100.00%
-10.00
Change In Working Capital
125.00
-20.89%
158.00
+156.43%
-280.00
-233.33%
-84.00
Change In Receivables
60.00
-67.03%
182.00
+146.91%
-388.00
+7.84%
-421.00
Change In Prepaid Assets
218.00
+3014.29%
7.00
-79.41%
34.00
+385.71%
7.00
Change In Payables And Accrued Expense
-395.00
-887.50%
-40.00
-138.83%
103.00
-65.55%
299.00
Change In Payable
-395.00
-887.50%
-40.00
-138.83%
103.00
-65.55%
299.00
Change In Account Payable
-96.00
-183.48%
115.00
-56.93%
267.00
-37.47%
427.00
Change In Other Working Capital
242.00
+2588.89%
9.00
+131.03%
-29.00
-193.55%
31.00
Investing Cash Flow
-2,305.00
-59.63%
-1,444.00
+9.92%
-1,603.00
+20.09%
-2,006.00
Cash Flow From Continuing Investing Activities
-2,305.00
-59.63%
-1,444.00
+9.92%
-1,603.00
+20.09%
-2,006.00
Net PPE Purchase And Sale
-528.00
+8.49%
-577.00
+11.09%
-649.00
+3.71%
-674.00
Purchase Of PPE
-603.00
-0.17%
-602.00
+7.24%
-649.00
+3.71%
-674.00
Sale Of PPE
75.00
+200.00%
25.00
0.00
0.00
Capital Expenditure
-603.00
-0.17%
-602.00
+7.24%
-649.00
+3.71%
-674.00
Net Investment Purchase And Sale
-18.00
-800.00%
-2.00
+95.45%
-44.00
-780.00%
-5.00
Purchase Of Investment
-20.00
-900.00%
-2.00
+95.45%
-44.00
-780.00%
-5.00
Sale Of Investment
2.00
—
—
0.00
Net Business Purchase And Sale
-1,758.00
-102.77%
-867.00
+5.25%
-915.00
+31.46%
-1,335.00
Purchase Of Business
-1,758.00
-102.77%
-867.00
+5.25%
-915.00
+31.46%
-1,335.00
Net Other Investing Changes
-1.00
-150.00%
2.00
-60.00%
5.00
-37.50%
8.00
Financing Cash Flow
-150.00
+82.92%
-878.00
-129.84%
-382.00
-16.11%
-329.00
Cash Flow From Continuing Financing Activities
-150.00
+82.92%
-878.00
-129.84%
-382.00
-16.11%
-329.00
Net Issuance Payments Of Debt
1,247.00
+125.50%
553.00
-31.05%
802.00
-14.77%
941.00
Issuance Of Debt
9,840.00
+483.98%
1,685.00
-73.61%
6,384.00
+77.33%
3,600.00
Repayment Of Debt
-8,593.00
-659.10%
-1,132.00
+79.72%
-5,582.00
-109.93%
-2,659.00
Long Term Debt Issuance
9,840.00
+483.98%
1,685.00
-73.61%
6,384.00
+77.33%
3,600.00
Long Term Debt Payments
-8,593.00
-659.10%
-1,132.00
+79.72%
-5,582.00
-109.93%
-2,659.00
Net Long Term Debt Issuance
1,247.00
+125.50%
553.00
-31.05%
802.00
-14.77%
941.00
Short Term Debt Issuance
—
—
2,384.00
+1.45%
2,350.00
Short Term Debt Payments
—
—
-2,709.00
-33.78%
-2,025.00
Net Short Term Debt Issuance
—
—
-325.00
-200.00%
325.00
Net Common Stock Issuance
-1,244.00
+7.85%
-1,350.00
-36.09%
-992.00
+15.07%
-1,168.00
Common Stock Payments
-1,244.00
+7.85%
-1,350.00
-36.09%
-992.00
+15.07%
-1,168.00
Repurchase Of Capital Stock
-1,244.00
+7.85%
-1,350.00
-36.09%
-992.00
+15.07%
-1,168.00
Proceeds From Stock Option Exercised
-67.00
-4.69%
-64.00
-4.92%
-61.00
+14.08%
-71.00
Net Other Financing Charges
-86.00
-405.88%
-17.00
+87.02%
-131.00
-322.58%
-31.00
Changes In Cash
199.00
-49.49%
394.00
+140.24%
164.00
+318.67%
-75.00
Effect Of Exchange Rate Changes
79.00
+216.18%
-68.00
-1600.00%
-4.00
+94.67%
-75.00
Beginning Cash Position
1,702.00
+23.69%
1,376.00
+13.16%
1,216.00
-10.98%
1,366.00
End Cash Position
1,980.00
+16.33%
1,702.00
+23.69%
1,376.00
+13.16%
1,216.00
Free Cash Flow
2,051.00
-2.98%
2,114.00
+40.93%
1,500.00
-5.42%
1,586.00
Interest Paid Supplemental Data
647.00
+9.85%
589.00
+5.94%
556.00
+46.70%
379.00
Income Tax Paid Supplemental Data
—
295.00
-13.24%
340.00
+33.33%
255.00
Change In Income Tax Payable
-299.00
-92.90%
-155.00
+5.49%
-164.00
-28.13%
-128.00
Change In Tax Payable
-299.00
-92.90%
-155.00
+5.49%
-164.00
-28.13%
-128.00
Earnings Losses From Equity Investments
-22.00
-340.00%
-5.00
0.00
-100.00%
12.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category